Strategic partnering
Thiopeutics is seeking strategic relationships with biotechnology and pharmaceutical partners, non-dilutive federal funding programs, and mission-aligned investors to advance our discovery-stage platform toward IND-enabling development. We are particularly interested in engaging with agencies such as BARDA and ARPA-H, whose mandates align with next-generation medical countermeasures for opioid-induced respiratory depression and related indications.
We welcome conversations with organizations interested in co-development, sponsored research, licensing, or funding collaborations at this discovery stage.
News and updates
Program updates, scientific presentations, and partnership milestones will be posted here as they become available.